California Public Employees Retirement System Sells 9,796 Shares of Corteva, Inc. $CTVA

California Public Employees Retirement System cut its position in shares of Corteva, Inc. (NYSE:CTVA) by 0.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,345,578 shares of the company’s stock after selling 9,796 shares during the quarter. California Public Employees Retirement System owned about 0.20% of Corteva worth $112,638,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. Brighton Jones LLC raised its position in shares of Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after acquiring an additional 11,760 shares in the last quarter. Woodline Partners LP boosted its position in shares of Corteva by 40.3% during the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Corteva by 62.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after purchasing an additional 980 shares in the last quarter. Cresset Asset Management LLC grew its stake in Corteva by 2.6% during the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after purchasing an additional 181 shares during the period. Finally, Jump Financial LLC acquired a new stake in Corteva during the second quarter worth approximately $1,464,000. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

Shares of CTVA opened at $87.42 on Friday. The business’s fifty day moving average is $80.86 and its 200 day moving average is $78.19. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $88.22. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The stock has a market cap of $58.47 billion, a P/E ratio of 51.43, a P/E/G ratio of 2.67 and a beta of 0.56.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same quarter in the previous year, the business posted $1.13 EPS. Corteva’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date was Monday, June 1st. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Zacks Research raised Corteva from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. Morgan Stanley lifted their price objective on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. Jefferies Financial Group boosted their target price on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Royal Bank Of Canada increased their target price on shares of Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a research note on Thursday, May 7th. Finally, BNP Paribas Exane raised their price target on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.95.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.